These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2475682)

  • 1. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
    Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
    Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning.
    Neutel JM; Alderman M; Anders RJ; Weber MA
    Am Heart J; 1996 Dec; 132(6):1202-6. PubMed ID: 8969572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response.
    Cubeddu LX; Aranda J; Singh B; Klein M; Brachfeld J; Freis E; Roman J; Eades T
    JAMA; 1986 Oct 24-31; 256(16):2214-21. PubMed ID: 3531560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of slow-release verapamil on blood pressure and cardiovascular system in essential hypertension.
    Meric M; Adalet K; Erzengin F; Korkut F; Okur O; Büyüköztürk K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S42-4. PubMed ID: 2475684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
    Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
    J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy of sustained-release verapamil.
    Zachariah PK; Sheps SG; Oshrain C; Schirger A; Stein WJ
    J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH; Eisen G; Charlap S; Strom JA
    J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK; Sheps SG; Schriger A
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.